Surgical Site Infection Control

Surgical Site Infection Control

Surgical site infections are the kind of infections that originate at the site of invasive surgery. These infections can be superficial, i.e., on the skin or may proliferate to other body organs as well. For the same reason, these infections are one of the major parts of healthcare-associated infections(HCAI). The Centers for Disease Control and Prevention in U.S. has stated tools and guidelines to help patients understand these surgical site infections and take appropriate measures to protect their own health. The basic types of surgical site infections are superficial incisional SSI, deep incisional SSI, and organ or space SSI. Various types of surgeries can cause this situation like caesarean section, gastric bypass, cataract surgery, and dental restoration. There are numerous factors leading to the development of this market, including innovations in standards and infrastructure of the healthcare sector, rising cases of surgical and operating room development worldwide, increase in trends of maintaining hygiene and sanitation. also, surge in government policies for the welfare of public and rise in demand for minimally invasive procedures are driving the growth of the market during the forecast period.

The Surgical Site Infection Control Market is expected to grow at a steady rate of around 4% owing to the increasing surgical procedures globally. An astounding range of 310 million major surgeries are performed each year worldwide; approximately 40 to 50 million in US and nearly 20 million in Europe. Several factors, such as unhygienic practices, lack of sanitation and sterilization are leading causes of surgical site infection globally. Apart from this, the introduction of new products in the market is also driving the market’s growth during the forecast period. This leads to an increase in a number of such cases worldwide. Facts stated by The Journal of the American Medical Association (JAMA) convey that surgical site infections Infections occur in nearly 0.5% to 3% of patients going through surgery. Organizations are taking multiple initiatives to help in preventing this ailment. For instance, the World Health Organization has updated its global guidelines for the prevention of surgical site infection in November,2022.

• Based on type of infection, the market is segmented into superficial incisional SSI, deep incisional SSI and organ or space SSI. The superficial incisional SSI segment held the maximum share in the global market in 2022. Superficial incisional SSI usually occurs in the body part which has been recently operated. The signs may include localized signs such as redness, heat, swelling at the site of the incision, pain or the drainage of pus. As per hospital advisories, thirty days of strict monitoring is done with the help of wound care dressing, disinfectants, and surgical drapes in all types of surgeries to prevent superficial incisional SSI. According to the reports of the National Institute of Health in June 2023, superficial incisional SSI were most prominent with the share of 50% before as well as after the COVID-19 pandemic.
• On the basis of procedure, the market is categorized into cesarean section, gastric bypass, cataract surgery, dental restoration and others. The caesarean section segment is expected to grow with high CAGR during the forecast period due to a surge in the premature deliveries throughout the world. Also cultural believes and healthcare quality could play a pivotal role in promoting the prevalence of C-sections. The World Health Organization reported the continuous rise in caesarean sections globally, there were more than 21% childbirths. It is estimated that nearly 29% of all births in 2030 are expected to take place via cesarean section.
• On the basis of product, the market is differentiated into skin preparation solution, surgical scrubs, hair clippers, surgical irrigation, surgical gloves, surgical drapes, manual reprocessors solution, disinfectants, medical nonwovens and others. Surgical- gloves and disinfectants segment were observed to be significant in the market in the forecast period. The rising demand for minimally invasive surgery is also a propelling factor for this segment which is responsible for its prevalence. Medical device companies are engrossed in launching such medical products in demand. For instance, Mediland launches advanced Surgical Table and SurgicalLight in 2021.
• Based on the end use, the market is segmented into hospitals, ambulatory surgical centers and others. The hospitals held the significant share in the surgical site infection control market in 2021. This is due to high adoption of surgical site infection control systems in hospitals as most surgeries are performed in hospital settings. Apart from this, the growing number of hospitals is also propelling the segmental growth. For instance, according to the American Hospital Association, there were about 6,100 hospitals in the U.S. in 2022, which comprised of community hospitals run by non-profit organizations as well as state and local governments.
• For a better understanding of the market adoption of the surgical site infection control, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is believed to be dominating in 2022 due to the rising number of patients and increasing healthcare providers in the nation. Further, the guidelines and initiatives by government is also driving the market growth during the forecast period. For instance, The National Institute for Health and Care Excellence (NICE) released guidelines regarding surgical site infections: prevention and treatment in August 2020. Over the projection period, this is expected to increase demand for surgical site infection control initiatives in this region.
• Some of the major players operating in the market include 3M; Becton Dickinson, and Company; BioMérieux, SA; Getinge AB; Johnson & Johnson Limited; Sotera Health Company; Medtronic Private Limited; Prescient Surgical; GAMA Healthcare Ltd.; ANSELL LTD.